Literature DB >> 26343838

Alcohol use disorders.

Jason P Connor1, Paul S Haber2, Wayne D Hall3.   

Abstract

Alcohol use disorders are common in developed countries, where alcohol is cheap, readily available, and heavily promoted. Common, mild disorders often remit in young adulthood, but more severe disorders can become chronic and need long-term medical and psychological management. Doctors are uniquely placed to opportunistically assess and manage alcohol use disorders, but in practice diagnosis and treatment are often delayed. Brief behavioural intervention is effective in primary care for hazardous drinkers and individuals with mild disorders. Brief interventions could also encourage early entry to treatment for people with more-severe illness who are underdiagnosed and undertreated. Sustained abstinence is the optimum outcome for severe disorder. The stigma that discourages treatment seeking needs to be reduced, and pragmatic approaches adopted for patients who initially reject abstinence as a goal. To engage people in one or more psychological and pharmacological treatments of equivalent effectiveness is more important than to advocate a specific treatment. A key research priority is to improve the diagnosis and treatment of most affected people who have comorbid mental and other drug use disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26343838     DOI: 10.1016/S0140-6736(15)00122-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

1.  Prevalence, incidence, recovery, and recurrence of alcohol use disorders from childhood to age 30.

Authors:  John R Seeley; Richard F Farmer; Derek B Kosty; Jeff M Gau
Journal:  Drug Alcohol Depend       Date:  2018-10-24       Impact factor: 4.492

2.  Drink goal difficulty effect on outcomes in moderation-based alcohol treatment for sexual minority men.

Authors:  Svetlana Levak; Alexis N Kuerbis; Jon Morgenstern
Journal:  J Subst Abuse Treat       Date:  2020-01-09

3.  Does change in self-perceived problem drinker identity relate to change in alcohol use? An examination of nontreatment seeking hazardous drinkers.

Authors:  Kevin S Montes; Ronda L Dearing; Eric D Claus; Katie Witkiewitz
Journal:  Psychol Addict Behav       Date:  2017-08-14

4.  The association between alcohol abuse and neuroendocrine system dysregulation: Race differences in a National sample.

Authors:  Yusuf Ransome; Natalie Slopen; Oskar Karlsson; David R Williams
Journal:  Brain Behav Immun       Date:  2017-07-24       Impact factor: 7.217

5.  Method effects of the relation between family history of alcoholism and parent reports of offspring impulsive behavior.

Authors:  Angela M Haeny; Andrew K Littlefield; Phillip K Wood; Kenneth J Sher
Journal:  Addict Behav       Date:  2018-07-30       Impact factor: 3.913

6.  An Examination of Alcohol Use Disorder Symptoms and Neighborhood Disorganization from Age 21 to 39.

Authors:  Christopher Cambron; Rick Kosterman; Isaac C Rhew; Richard F Catalano; Katarina Guttmannova; J David Hawkins
Journal:  Am J Community Psychol       Date:  2017-09

Review 7.  Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease.

Authors:  Lorenzo Leggio; Mary R Lee
Journal:  Am J Med       Date:  2016-10-29       Impact factor: 4.965

8.  Different Effects of Knockouts in ALDH2 and ACSS2 on Embryonic Stem Cell Differentiation.

Authors:  Ryan N Serio; Changyuan Lu; Steven S Gross; Lorraine J Gudas
Journal:  Alcohol Clin Exp Res       Date:  2019-08-05       Impact factor: 3.455

9.  Elevated inflammation in association with alcohol abuse among Blacks but not Whites: results from the MIDUS biomarker study.

Authors:  Yusuf Ransome; Natalie Slopen; Oskar Karlsson; David R Williams
Journal:  J Behav Med       Date:  2017-12-11

10.  Impact Of Medicaid Expansion On Coverage And Treatment Of Low-Income Adults With Substance Use Disorders.

Authors:  Mark Olfson; Melanie Wall; Colleen L Barry; Christine Mauro; Ramin Mojtabai
Journal:  Health Aff (Millwood)       Date:  2018-08       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.